Historical record - last NADAC effective date: 3/21/2018
Product Information
GLUMETZA ER 500 MG TABLET is a brand product labeled by Santarus Inc., priced at $49.4836 per EA under NDC 68012000213. Its NADAC has been published 198 times since Jul 23, 2014.
FDA first approved this application on Jun 3, 2005.
The High Outlier badge above means this manufacturer's average price in the metformin hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Santarus Inc.NDC
68012000213
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
3/21/2018
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021748FDA Approved
6/3/2005
On Market Since
8/1/2006
Pharmacological Classes
Price Statistics
The NADAC for GLUMETZA ER 500 MG TABLET has been published 198 times since Jul 23, 2014, and over the history we have for it it has risen 799.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.4836 per EA |
|---|---|
| All-time high | $50.0907 (Jun 14, 2017) |
| All-time low | $5.5015 (Jul 23, 2014) |
| Median price | $49.4836 |
| Average price | $38.4533 |
| Largest weekly change | +500.0% (Jun 24, 2015) |
| Weeks tracked | 198 |
| Tracking since | Jul 23, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+799.5%
Last surveyed Jan 30, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLUMETZA ER 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLUMETZA ER 500 MG TABLET, manufactured by Santarus Inc., is $49.4836 per EA (NDC 68012000213), effective Jan 30, 2019.
How has the price of GLUMETZA ER 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLUMETZA ER 500 MG TABLET has risen 799.5%. It has been tracked across 198 weekly CMS publications since Jul 23, 2014.
What are the highest and lowest recorded NADAC prices for GLUMETZA ER 500 MG TABLET?
Since Jul 23, 2014, the NADAC for GLUMETZA ER 500 MG TABLET has ranged from a low of $5.5015 (Jul 23, 2014) to a high of $50.0907 (Jun 14, 2017), with a median of $49.4836 per EA.
Are there cheaper alternatives to GLUMETZA ER 500 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL 500 MG TABLET, is $0.0142 per EA — about 99% below GLUMETZA ER 500 MG TABLET.
Who manufactures GLUMETZA ER 500 MG TABLET?
GLUMETZA ER 500 MG TABLET (NDC 68012000213) is labeled by Santarus Inc., and CMS classifies it as a brand product.